Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast Cancer

被引:14
|
作者
Strati, Titika-Marina [1 ]
Kotoula, Vassiliki [2 ,3 ]
Kostopoulos, Ioannis [2 ]
Manousou, Kyriaki [4 ]
Papadimitriou, Christos [5 ]
Lazaridis, Georgios [6 ]
Lakis, Sotiris [3 ]
Pentheroudakis, George [7 ]
Pectasides, Dimitrios [8 ]
Pazarli, Elissavet [9 ]
Christodoulou, Christos [10 ]
Razis, Evangelia [11 ]
Pavlakis, Kitty [12 ]
Magkou, Christina [13 ]
Chrisafi, Sofia [3 ]
Aravantinos, Gerasimos [14 ]
Bafaloukos, Dimitrios [15 ]
Papakostas, Pavlos [16 ]
Gogas, Helen [17 ]
Kalogeras, Konstantine T. [3 ,18 ]
Fountzilas, George [3 ,19 ]
机构
[1] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Surg 3, Sch Hlth Sci,Fac Med, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Sch Hlth Sci, Fac Med, Dept Pathol, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Hellen Fdn Canc Res, Mol Oncol Lab, Thessaloniki, Greece
[4] Hellen Cooperat Oncol Grp, Data Off, Biostat Sect, Athens, Greece
[5] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece
[6] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Dept Med Oncol, Sch Hlth Sci,Fac Med, Thessaloniki, Greece
[7] Ioannina Univ Hosp, Ioannina, Greece
[8] Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens, Greece
[9] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Dept Pathol, Sch Hlth Sci,Fac Med, Thessaloniki, Greece
[10] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece
[11] Hygeia Hosp, Dept Med Oncol 3, Athens, Greece
[12] Univ Athens, Sch Med, Dept Pathol, Athens, Greece
[13] Evangelismos Med Ctr, Dept Pathol, Athens, Greece
[14] Agii Anargiri Canc Hosp, Dept Med Oncol 2, Athens, Greece
[15] Metropolitan Hosp, Dept Med Oncol 1, Piraeus, Greece
[16] Hippokrateion Hosp, Oncol Unit, Athens, Greece
[17] Univ Athens, Sch Med, Laiko Gen Hosp, Dept Med 1, Athens, Greece
[18] Hellen Cooperat Oncol Grp, Data Off, Translat Res Sect, Athens, Greece
[19] Aristotle Univ Thessaloniki, Thessaloniki, Greece
关键词
Notch2; Notch3; Jagged1; triple-negative breast cancer; prognosis; TUMOR-INFILTRATING LYMPHOCYTES; DENSE SEQUENTIAL CHEMOTHERAPY; RANDOMIZED PHASE-III; TISSUE MICROARRAYS; THERAPEUTIC TARGET; EXPRESSION; EPIRUBICIN; INHIBITION; JAG1; IDENTIFICATION;
D O I
10.21873/anticanres.11570
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The Notch pathway has been implicated in triple-negative breast cancer (TNBC). Herein, we studied the subcellular localization of the less investigated Notch2 and Notch3 and that of the Jagged1 (Jag1) ligand in patients with operable TNBC. Patients and Methods: We applied immunohistochemistry for Notch2, Notch3 and Jag1 in 333 tumors from TNBC patients treated with adjuvant anthracycline-based chemotherapy. We evaluated cytoplasmic (c), membranous (m) and nuclear (n) protein localization. Results: c-Notch2 (35% positive tumors), c-Notch3 ( 63%), c-Jag1 (43%), m-Notch3 (23%) and n-Jag1 (17%) were analyzed individually and by using hierarchical clustering for prognostic evaluation. Upon multivariate analysis, compared to high m-Notch3 in the absence of n-Jag1 (cluster 4), all other marker combinations (clusters 1, 2, 3) conferred significantly higher risk for relapse (p<0.05). Conclusion: Specific Notch3 and Jag1 subcellular localization patterns may provide clues for the behavior of the tumors and potentially for Jag1 targeting in TNBC patients.
引用
收藏
页码:2323 / 2334
页数:12
相关论文
共 50 条
  • [41] Prognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer
    Ceprnja, Toni
    Mrklic, Ivana
    Peric Balja, Melita
    Marusic, Zlatko
    Blazicevic, Valerija
    Spagnoli, Giulio Cesare
    Juretic, Antonio
    Capkun, Vesna
    Tecic Vuger, Ana
    Vrdoljak, Eduard
    Tomic, Snjezana
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (06):
  • [42] Inhibition of Notch enhances efficacy of immune checkpoint blockade in triple-negative breast cancer
    Shen, Qiang
    Murakami, Kiichi
    Sotov, Valentin
    Butler, Marcus
    Ohashi, Pamela S.
    Reedijk, Michael
    SCIENCE ADVANCES, 2024, 10 (44):
  • [43] Targeting Notch signaling in cancer stem-like cells of triple-negative breast cancer
    Murphy, Adrienne M.
    Ucar, Ayse D.
    Miele, Lucio
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [44] Daurisoline Inhibits Progression of Triple-Negative Breast Cancer by Regulating the γ-Secretase/Notch Axis
    Zhan, Xiangyi
    Chen, Xiaoyong
    Feng, Mei
    Yao, Kuo
    Yang, Kefan
    Jia, Hui
    BIOMOLECULES & THERAPEUTICS, 2025, 33 (02) : 331 - 343
  • [45] The Vacuolar ATPase a2-subunit regulates Notch signaling in triple-negative breast cancer cells
    Pamarthy, Sahithi
    Jaiswal, Mukesh K.
    Kulshreshtha, Arpita
    Katara, Gajendra K.
    Gilman-Sachs, Alice
    Beaman, Kenneth D.
    ONCOTARGET, 2015, 6 (33) : 34206 - 34220
  • [46] 佐剂关节炎大鼠肺功能变化与Notch1、Notch2/Jagged1、Jagged2通路的相关性
    万磊
    刘健
    程园园
    冯云霞
    刘磊
    黄传兵
    汪元
    安徽医科大学学报, 2012, 47 (10) : 1156 - 1160
  • [47] Expressions and Prognostic Values of Notch3 and DLL4 in Human Breast Cancer
    Wang, Lin
    Cao, Ge
    Li, Wei
    Chen, Xiao-Wen
    Xiong, Shi-Shuang
    Mu, Ya-Nan
    Jiang, Jin-Fang
    Yang, Lan
    Zhang, De-Rui
    Cao, Yu-Wen
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [48] Expressions and Prognostic Values of Notch3 and DLL4 in Human Breast Cancer
    Wang, Lin
    Cao, Ge
    Li, Wei
    Chen, Xiao-Wen
    Xiong, Shi-Shuang
    Mu, Ya-Nan
    Jiang, Jin-Fang
    Yang, Lan
    Zhang, De-Rui
    Cao, Yu-Wen
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [49] Identification of INFG/STAT1/NOTCH3 as γ-Mangostin's potential targets for overcoming doxorubicin resistance and reducing cancer-associated fibroblasts in triple-negative breast cancer
    Lawal, Bashir
    Wu, Alexander T. H.
    Chen, Chien-Hsin
    George, T. A.
    Wu, Szu-Yuan
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 163
  • [50] Brucine Inhibits Bone Metastasis of Breast Cancer Cells by Suppressing Jagged1/Notch1 Signaling Pathways
    HU Ke-fei
    KONG Xiang-ying
    ZHONG Mi-cun
    WAN Hong-ye
    LIN Na
    PEI Xiao-hua
    Chinese Journal of Integrative Medicine , 2017, (02) : 110 - 116